Precure Targeted Accrual and Rapid Growth in Enrollment Trial Study

The goal of this observational study is to 1) better understand and predict biological processes before disease begins or is identified, 2) study genomic and environmental contributors to disease, 3) identify ways to stop disease advancement before it becomes serious or complex, and 4) identify potential targets for disease therapy. Participants will be asked to: * collect biological samples

NCT Number	NCT07756320
Lead Sponsor	Mayo Clinic
Conditions	Exposure, Environmental, Genetic Predisposition
Enrollment	100,000 participants
Start Date	2026-08-07
Primary Completion	2030-12 (estimated)
Study Completion	2035-12 (estimated)
Updated on ClinicalTrials.gov	2026-08-10